9:00am - 5:00pm

Office Hours Mon. - Fri.

800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Vinorelbine in Mesothelioma

Estimated reading time: < 1 min

Condition

Mesothelioma

Estimated Enrollment: 200

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment

Study ID Numbers: UNOLE 0329

Study First Received: May 9, 2014

Last Updated: April 7, 2017

Estimated Primary Completion Date: March 1, 2018

Primary Outcome Measures:

Overall Survival|Progression Free Survival|Number of serious adverse events reported|BRCA1 status in blood and tumour samples

Sponsors and Collaborators:

Wales Cancer Trials Unit|Pierre Fabre Laboratories

Result Received: No Study Results Posted

Website Link: https://ClinicalTrials.gov/show/NCT02139904

Was this article helpful?
Views: 57